Clinical Trials Sponsored by Research & Development Concierge Company

Total 310 results

Zona Health, Inc
Research & Development Concierge Company

Terminated

A Pivotal Study To Evaluate The Effectiveness of Isometric Handgrip Therapy In Prehypertensive And Hypertensive Patients

Hypertension, Systolic

United States
SPD Development Company Limited
Illingworth Research Ltd

Completed

Project-0027. Lay User Usage Study

Pregnancy

United Kingdom
Janssen Research & Development, LLC
Bristol Myers Squibb Company (BMS)

Recruiting

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)

Ischemic Stroke; Ischemic Attack, Transient

Italy, United States, Hong Kong, Japan, Taiwan, South Africa, Korea, Republic of, Israel, United Kingdom, Argentina, Belgium, New Zealand, Canada, Germany, Czechia, Denmark, Mexico, Croatia, France, Australia, Brazil, China, Hungary, ... and more
U.S. Army Medical Research and Development Command

Not yet recruiting

Treatment of Hemorrhagic Fever With Ribavirin

Hemorrhagic Fever
U.S. Army Medical Research and Development Command

No longer available

Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)

Severe Acute Respiratory Syndrome Coronavirus 2

United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
U.S. Army Medical Research and Development Command

Active, not recruiting

Combination HTNV and PUUV DNA Vaccine

Hantaan Virus Disease, Puumala Virus

United States
U.S. Army Medical Research and Development Command

No longer available

Expanded Access Remdesivir (RDV; GS-5734™)

Coronavirus Disease 2019

United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
U.S. Army Medical Research and Development Command

Completed

Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets

Thrombocytopenia

United States
U.S. Army Medical Research and Development Command

Enrolling by invitation

Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

Tularemia

United States
U.S. Army Medical Research and Development Command

Completed

Ascending Doses of Autologous FDP vs FFP (FDP)

Freeze Dried Plasma in Healthy Volunteers

United States
U.S. Army Medical Research and Development Command

Completed

A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis

Old World Cutaneous Leishmaniasis

Tunisia
U.S. Army Medical Research and Development Command

Active, not recruiting

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 (VEE C-84)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Enrolling by invitation

Ribavirin for Hemorrhagic Fever With Renal Syndrome

Hemorrhagic Fever With Renal Syndrome

Korea, Republic of
U.S. Army Medical Research and Development Command

No longer available

Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis

Leishmaniasis, Cutaneous

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis Population (APCG)

Gingivitis | Plaque

United States
U.S. Army Medical Research and Development Command

Completed

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine (MP-12)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms (BIMA)

Post-Concussion Syndrome | Traumatic Brain Injury With Brief Loss of Consciousness

United States
U.S. Army Medical Research and Development Command

Completed

TDENV PIV and LAV Dengue Prime-boost Strategy

Dengue

United States
U.S. Army Medical Research and Development Command

Completed

Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama

Cutaneous Leishmaniasis

Panama
U.S. Army Medical Research and Development Command

Withdrawn

Phase 1 meCS6 + LT(R192G) Vaccine Study

Diarrhea

United States
U.S. Army Medical Research and Development Command

Completed

Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama

Leishmaniasis, Cutaneous

Panama
U.S. Army Medical Research and Development Command

Completed

Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease (DENV-1 PIV)

Dengue Fever

United States
U.S. Army Medical Research and Development Command

Completed

Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)

Cutaneous Leishmaniasis

Tunisia
U.S. Army Medical Research and Development Command

Recruiting

An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

Stress Disorders, Post-Traumatic

United States
U.S. Army Medical Research and Development Command

Not yet recruiting

Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults (VEE)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine

Dengue Virus

United States
U.S. Army Medical Research and Development Command

Unknown

The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome in Trauma Patients (NIRS)

Anterior Tibial Compartment Syndrome

United States
U.S. Army Medical Research and Development Command

Completed

A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine

Hantaan Virus

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)

Shigellosis | Bacillary Dysentery

United States
U.S. Army Medical Research and Development Command

Unknown

Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine

Western Equine Encephalitis

United States
U.S. Army Medical Research and Development Command

Completed

Safety Evaluation of a Q-fever Vaccine, NDBR 105

Q Fever

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

Tularemia

United States
U.S. Army Medical Research and Development Command

Completed

Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults (RVEc)

Ricin Poisoning

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine (EEE)

Eastern Equine Encephalitis

United States
U.S. Army Medical Research and Development Command

Completed

Reference Values for Non-invasive Hydration Status Markers H10-14

Value Orientation

United States
U.S. Army Medical Research and Development Command

Completed

Western Equine Encephalitis Vaccine, Inactivated (WEE)

Virus

United States
U.S. Army Medical Research and Development Command

Completed

Phase 1 Safety and Immunogenicity of Meningococcal Vaccine (HOPS)

Meningococcal Infection, Group B

United States
U.S. Army Medical Research and Development Command

Completed

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

HIV Infections

United States
U.S. Army Medical Research and Development Command

Completed

Challenge Study of an ETEC Vaccine

Enteritis; Escherichia Coli, Enterotoxigenic

United States
U.S. Army Medical Research and Development Command

Completed

Invaplex 50 Vaccine Dose-Ranging

Diarrhea

United States
U.S. Army Medical Research and Development Command

Completed

Weekly Dosing of Malarone ® for Prevention of Malaria (MALWEEK)

Malaria

United States
U.S. Army Medical Research and Development Command

Recruiting

Safety and Immunogenicity of a Hantaan Virus DNA Vaccine and a Puumala Virus DNA Vaccine, For The Prevention of Hemorrhagic Fever With Renal Syndrome

Hantaan Virus Nephropathy | Puumala Virus Nephropathy

United States
U.S. Army Medical Research and Development Command

Recruiting

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Recruiting

Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever

Viral Hemorrhagic Fever

Germany
U.S. Army Medical Research and Development Command

Completed

Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) (MMB4(DMS))

Safety and Efficacy

United States
U.S. Army Medical Research and Development Command

Available

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Smallpox | Monkeypox
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54

Malaria,Falciparum

United States
U.S. Army Medical Research and Development Command

Completed

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States

Clinical Trials Sponsored by Research & Development Concierge Company

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations